Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2010 | 1 |
2012 | 1 |
2014 | 1 |
2015 | 2 |
2017 | 1 |
2020 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.
N Engl J Med. 2023 Apr 20;388(16):1533-1534. doi: 10.1056/NEJMc2214773. Epub 2023 Apr 5.
N Engl J Med. 2023.
PMID: 37018470
No abstract available.
Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants.
Griffin MP, Yuan Y, Takas T, Domachowske JB, Madhi SA, Manzoni P, Simões EAF, Esser MT, Khan AA, Dubovsky F, Villafana T, DeVincenzo JP; Nirsevimab Study Group.
Griffin MP, et al.
N Engl J Med. 2020 Jul 30;383(5):415-425. doi: 10.1056/NEJMoa1913556.
N Engl J Med. 2020.
PMID: 32726528
Clinical Trial.
Item in Clipboard
A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults.
Ostergaard L, Vesikari T, Absalon J, Beeslaar J, Ward BJ, Senders S, Eiden JJ, Jansen KU, Anderson AS, York LJ, Jones TR, Harris SL, O'Neill R, Radley D, Maansson R, Prégaldien JL, Ginis J, Staerke NB, Perez JL; B1971009 and B1971016 Trial Investigators.
Ostergaard L, et al.
N Engl J Med. 2017 Dec 14;377(24):2349-2362. doi: 10.1056/NEJMoa1614474.
N Engl J Med. 2017.
PMID: 29236639
Free article.
Clinical Trial.
Item in Clipboard
Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.
Richmond PC, Marshall HS, Nissen MD, Jiang Q, Jansen KU, Garcés-Sánchez M, Martinón-Torres F, Beeslaar J, Szenborn L, Wysocki J, Eiden J, Harris SL, Jones TR, Perez JL; 2001 Study Investigators.
Richmond PC, et al.
Lancet Infect Dis. 2012 Aug;12(8):597-607. doi: 10.1016/S1473-3099(12)70087-7. Epub 2012 May 7.
Lancet Infect Dis. 2012.
PMID: 22569484
Clinical Trial.
Item in Clipboard
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered to older infants and children naïve to pneumococcal vaccination.
Wysocki J, Brzostek J, Szymański H, Tetiurka B, Toporowska-Kowalska E, Wasowska-Królikowska K, Sarkozy DA, Giardina PC, Gruber WC, Emini EA, Scott DA.
Wysocki J, et al. Among authors: tetiurka b.
Vaccine. 2015 Mar 30;33(14):1719-25. doi: 10.1016/j.vaccine.2015.02.005. Epub 2015 Feb 17.
Vaccine. 2015.
PMID: 25698485
Clinical Trial.
Item in Clipboard
Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial.
Carbonell-Estrany X, Simões EA, Dagan R, Hall CB, Harris B, Hultquist M, Connor EM, Losonsky GA; Motavizumab Study Group.
Carbonell-Estrany X, et al.
Pediatrics. 2010 Jan;125(1):e35-51. doi: 10.1542/peds.2008-1036. Epub 2009 Dec 14.
Pediatrics. 2010.
PMID: 20008423
Clinical Trial.
Item in Clipboard
A prospective observational study of oseltamivir safety and tolerability in infants and young children ≤24 months.
Rath BA, Blumentals WA, Miller MK, Starzyk K, Tetiurka B, Wollenhaupt M.
Rath BA, et al. Among authors: tetiurka b.
Pharmacoepidemiol Drug Saf. 2015 Mar;24(3):286-96. doi: 10.1002/pds.3707. Epub 2014 Oct 21.
Pharmacoepidemiol Drug Saf. 2015.
PMID: 25331369
Item in Clipboard
Cite
Cite